The validation of the 2010 <scp>A</scp>merican <scp>A</scp>ssociation for the <scp>S</scp>tudy of <scp>L</scp>iver <scp>D</scp>iseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area
Ming‐Tsung Lin(Chang Gung University), Tsung‐Hui Hu(National Sun Yat-sen University), Kuo‐Chin Chang(Kaohsiung Chang Gung Memorial Hospital), Cheng‐Kung Wu(Chang Gung University), Yi‐Hao Yen(Chang Gung University), Po‐Lin Tseng(Chang Gung University), Yeh‐Pin Chou(Chang Gung University), Hock‐Liew Eng(Chang Gung University), Chih‐Chi Wang(Kaohsiung Chang Gung Memorial Hospital), Yu‐Fan Cheng(Shanghai Medical College of Fudan University), Ming‐Chao Tsai(Kaohsiung Chang Gung Memorial Hospital)
Cited by 7
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217